Measuring oxygen extraction fraction (OEF) may prove a useful clinical tool for assessing brain oxygen consumption. Dual-calibrated fMRI is used to map voxel-wise OEF across grey-matter and requires respiratory challenge (hypercapnia and hyperoxia). However, this method presents challenges to clinical implementation. Conversely, OxFlow provides a global estimate of OEF, has a shorter acquisition time and does not require respiratory challenge. Here we examine the relationship between both approaches for measuring OEF, revealing a significant association between methods. While further investigation is required, OxFlow may offer additional clinical utility for measuring cerebral oxygen consumption.
This abstract and the presentation materials are available to members only; a login is required.